Methods for suppressing neovascularization using ephrinB2

Details for Australian Patent Application No. 2005261363 (hide)

Owner Aqumen Biopharmaceuticals K.K.

Inventors Fujisawa, Kimihiko; Ishibashi, Tatsuro; Kagimoto, Tadahisa; Hata, Yasuaki

Agent A.P.T. Patent and Trade Mark Attorneys

Pub. Number AU-B-2005261363

PCT Pub. Number WO2006/006079

Priority 60/558,999 05.04.04 US

Filing date 5 April 2005

Wipo publication date 19 January 2006

Acceptance publication date 30 July 2009

International Classifications

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

Event Publications

12 October 2006 PCT application entered the National Phase

  PCT publication WO2006/006079 Priority application(s): WO2006/006079

30 July 2009 Application Accepted

  Published as AU-B-2005261363

3 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005261410-A safe delivery system for agriculturally active material

2005261360-Low-power reconfigurable architecture for simultaneous implementation of distinct communication standards